STACEY SCHMIDT: Open Payments
NPI 1205920493 · TRINITY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,621 in 171 payments from 19 companies in 2025. Trend: 2023 $2,043 · 2024 $3,279 · 2025 $3,621
Food & beverage: $3,557Education: $65
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 24 | $622 |
| UCB, Inc. | 24 | $432 |
| Botanix SB Inc | 14 | $328 |
| MAYNE PHARMA COMMERCIAL LLC | 13 | $286 |
| ABBVIE INC. | 23 | $286 |
| Galderma Laboratories, L.P. | 8 | $237 |
| Amgen Inc. | 10 | $223 |
| Incyte Corporation | 17 | $209 |
| Lilly USA, LLC | 6 | $179 |
| Regeneron Healthcare Solutions, Inc. | 6 | $179 |
Products named: TREMFYA, Bimzelx, SOFDRA, DUPIXENT, SKYRIZI, NEMLUVIO, OPZELURA, OTEZLA.
Industry payments across FL — which companies pay providers there.
